Properties and crystallization of a genetically engineered, water-soluble derivative of penicillin-binding protein 5 of Escherichia coli K12 by Ferreira, Luis C et al.
Eur. J. Biochem. ;7 / , 11-16(1988)
© FEBS 1988
Properties and crystallization of a genetically engineered, water-soluble derivative
of penicillin-binding protein 5 of Escherichia coli K12
Luis C. S. FERREIRA', Uli SCHWARZ', Wolfgang KECK ', Paulette CHARL1ER^ Otto DIDEBERG^ and Jean-Marie GHUYSEN^
' Abteilung Biochemie, Institut fur Entwicklungsbiologie, Tubingen
^ Laboratoire de Cristallographie and
^ Service de Microbiologie, Universite de Liege
(Received July 20/September 23, 1987) - EJB 87 0896
Derivatives of the Escherichia coli penicillin-binding protein 5 (PBP5) with truncated carboxyl terminals were
obtained by altering the carboxyl-coding end of the dacA gene. After cloning the modified dac.4 gene into a
runaway-replication-control plasmid, one clone that overproduced and excreted the desired protein into the
periplasm was used as a source for the isolation ofa water-soluble PBP5 (i.e. PBP5S). In PBP5S the carboxyl-
terminal 21-amino-acid region ofthe wild-type protein was replaced by a short 9-amino-acid segment. Milligram
amounts of PBP5S were purified by penicillin affinity chromatography in the absence of detergents or of chaotropic
agents. PBP5S was stable and possessed DD-carboxypeptidase activity without added Triton X-100. Upon reaction
with ['*C]benzylpenicillin it was converted into a rather short-lived acyl-enzyme complex, as observed with PBP5.
Both PBP5 and PBP5S were crystallized. In contrast to PBP5, PBP5S yielded enzymatically active, well-formed
prismatic crystals suitable for X-ray analysis.
The penicillin-binding proteins (PBPs) [1] and the fl-
lactamases [2] catalyse diflerent reactions and fulfill different
biological functions. Yet they share remarkable similarities.
They all accomodate /?-lactam antibiotics in their active sites
(for review see [3]). The penicillin-binding proteins and the
majority of the /?-lactamases are active-site-serine enzymes
that operate by a common acyl-enzyme mechanism [4, 5]. The
protein sequences around the active-site serine show high
homology [6 — 9]. Finally several ^-lactamases and the extra-
cellular DD-peptidase/PBP from Streptomyces R61 show great
similarity in their three-dimensional structure [10 — 13]. There-
fore, a possible evolutionary relationship between these differ-
ent proteins has been postulated [3, 12, 14]. This relationship
may be general and apply to all penicilling-binding and
penicillin-hydrolysing enzymes with a serine in their active
site. As a prerequisite for such a generalization, however, the
three-dimensional structure of membrane-bound penicillin-
binding proteins has to be established.
As a model compound for the crystallization and for
X-ray analysis, the penicillin-binding protein 5 from
Escherichia coli K12 was chosen for several reasons. It is the
major DD-carboxypeptidase in the E. coli envelope [15] where
it is anchored within the cytoplasmic membrane through a
short sequence at the carboxyl end [16]. A weak ^-lactam-
hydrolysing activity is associated with the protein [17]. With
a molecular mass of only 42 kDa, X-ray studies of its crystal
form should be relatively easy. The protein can be purified
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Abbreviation. PBP, penicillin-binding protein.
Enzymes. Lysozyme (EC 3.2.1.17); T4 DNA Iigase (EC 6.5.1.1);
DNA polymerase I (Klenow fragment) (EC 2.7.7.7); restriction
endonucleases: BamWl, EcoKl (EC 3.1.21.4); horseradish peroxidase
(EC 1.11.1.7).
in an enzymatically active form which binds penicillin
stoichiometrically. Finally gene cloning gives access to large
quantities ofthe desired protein [18].
MATERIALS AND METHODS
Reagents and enzymes
The restriction enzymes, BaBl and T4 Iigase were from
Boehringer Mannheim (Mannheim, FRG). The depsipep-
tide bisacetyl-L-lysyl-D-alanyl-D-lactate was from Serva
(Heidelberg, FRG) and 6-aminopenicillanic acid from Sigma
(Deisenhofen, FRG). CH-Sepharosc 4B and heparin-
Sepharose were from Pharmacia (Freiburg. FRG).
Bacterial strains and plasmids
E. coli HBlOl was used as the host strain throughout
the work. E. coli SP430, a PBP5S overproducer, was kindly
provided by Dr. B. G. Spratt. The plasmids pOU-61 [19],
pKK232-8 [20], and pBS59 [18] have been described pre-
viously and were donated by the authors. pWK-61 was con-
structed by insertion of a Hindlll-Sall fragment containing
the kanamycin-resistance gene of Tn5, into the partially
fia/31-digested ampicillin-resistance gene of pOU-61.
Gene manipulation techniques
Plasmids were isolated following the alkaline lysis pro-
cedure [21]. All other recombinant DNA techniques were
based on Maniatis et ai. [22].
Western blots and immunochemical tests
Proteins were transferred from acryiamide gels to nitrocel-
lulose sheets and PBP5-related proteins were identified with
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rabbit PBP5 antiserum and horseradish-peroxidase-conjugat-
ed goat anti-(rabbit antibody) as described by Towbin et al.
[23]. 4-Chloro-l-naphthol at 0.5 mg/ml was used as a sub-
strate for peroxidase.
[^*CjBenzylpenicillin-binding assays
The reaction with [''^C]benzylpenicillin (58.9 Ci/mol,
Amersham, UK) was carried out under saturating conditions
[17]. Samples were incubated for 10 min at 30 "C with 0.1 mM
radioactive penicillin, followed by addition ofa 100-fold ex-
cess of non-radioactive penicillin. Release of the bound
[''^C]benzylpenicilloyl residue from the acyl-enzymes was de-
termined from time-course experiments. The reactions were
stopped with buffer containing sodium dodecyl sulfate (SDS)
[24] and by maintaining the samples for 3 min in a boiling-
water bath. The radioactivity labelled PBPs were separated
by SDS/polyacrylamide gel electrophoresis and estimated by
fluorography.
Growth conditions and preparation of cell envelopes
Cells were grown in LB medium (1% tryptone, 0.5% yeast
extract, 0.5% sodium chloride) containing kanamycin (50 ng/
ml) at 28 "C, shifted to 42 °C at an absorbance of 0.3 (574 nm)
and incubated for an additional period of 3 h. The cells were
collected by centrifugation, suspended in 50 mM phosphate
buffer pH 7.0 containing 2 mM dithioerythritol and opened
with a French press (180001b in " ^ 124 MPa) or a sonic
disruptor. Membranes were isolated from cell extracts by
centrifugation at 35000 x g for 30 min at 4''C.
Solubilization ofthe membrane-bound PBPS
For the purification of native PBP5 the cell envelopes
isolated from the PBP5-overproducing E. coli Kl 2 SP430 were
suspended in 300 ml 50 mM sodium phosphate buffer pH 8.0
containing 2 mM mercaptoethanol and 2% Triton X-100, and
stirred for 1 h at 4°C. The insoluble material was eliminated
by centrifugation at 50000 x g for 45 min at 4°C.
Puriftcation of membrane-bound PBPS
Activated CH-Sepharose 4B (15 g) was suspended in
100 ml 0.1 M NaHCOs pH 8.0 containing 0.5 M NaCl and
800 mg 6-aminopenicillanic acid. After coupling, the 6-
aminopenicillanic-acid — CH-Sepharose 4B was washed and
added to the Triton X-100 membrane extract corresponding
to 300 g (wet weight) of E. coli K12 SP430. The suspension
was kept at 4"C with gentle stirring for 1 h. The resin was
collected on a sintered glass funnel, washed at 4°C with 100 ml
50 mM Tris/HCl buffer pH 8.0 containing 2 mM mer-
captoethanol and 1% Triton X-100 and then with 100 ml of
the same Tris/HCl buffer containing 1 M NaCl. This double
washing was repeated two more times except that, for the final
step, buffer without sodium chloride but with 0.2% Triton X-
100 was used. The covalently bound PBP5 was eluted with
freshly prepared 25 mM Tris/HCl pH 8.0 containing 1 mM
dithioerythritol, 0.2% Triton X-100 and 1 M hydroxylamine.
The resin was treated several times (4 — 6 cycles) with 15 ml
elution buffer at room temperature for 30 min, then with
another 15 ml at 30 "C and finally with 40 ml at 37 "C for
1 h. Each eluate was immediately dialysed against 3 x 500 ml
25 mM Tris/HCl pH 8.0 containing 1 mM dithioerythritol,
0.2% Triton X-100 and 0.5 mM NaCI. A sodium chloride
concentration above 0.3 M was necessary to avoid protein
precipitation. Using this procedure, PBP5 and PBP6 were
recovered unseparated but almost completely free of any other
proteins in the eluates. The eluates were pooled, dialysed and
loaded at a flow rate of 3 ml/h on a (0.9 x 10-cm) heparin-
Sepharose column previously equilibrated with 25 mM Tris/
HCl buffer pH S.O containing 1 mM dithioerythritol and
0.2% Triton X-100. The column was washed with 50 ml of
the same buffer and eluted with a linear NaCl gradient
(500 mM NaCl in 25 mM Tris/HCl, pH 8.0, 1 mM
dithioerythritol, 0.2% Triton X-100; 3 ml/h). PBP5 and PBP6
were eluted at 180 mM and 250 mM NaCl concentrations
respectively.
Puriftcation of water-soluble PBPSS
Exponential-phase cells of E. coli HB 101 transformed
with pLFl-5 were grown, harvested by centrifugation, sus-
pended in phosphate buffer and disrupted as described above.
Purification of PBP5S from the supernatant was achieved in
a single step by covalent penicillin affinity chromatography
on 6-aminopenicillanic-acid — CH-Sepharose. The procedure
described above for the purification of PBP5 was used except
that Triton X-100 was omitted. After a minimum of six wash-
ing cycles, PBP5S was eluted from the resin using a 25 mM
Tris/HCl buffer pH 8.0 containing 1 mM dithioerythritol and
1 M hydroxylamine. The samples were immediately dialysed
against 3 x 500 ml 25 mM Tris/HCl pH 8.0 containing 1 mM
dithioerythritol. Chromatography on heparin-Sepharose was
used as a means to concentrate the purified PBP5S (up to
13 mg/ml).
Assay for carboxypeptida.se activity
Carboxypeptidase activity was measured following an un-
pubhshed procedure developed by Dr J. Holtjc. The purified
PBP5 and PBP5S (1 nM) and Acz-Lys-D-Ala-D-lactate
(140 nM) were incubated together for 30 min at 37 "C in
25 mM Tris/HCl pH 8.0 containing 0.2 mM dithioerythritol.
The samples were maintained in a boiling water bath for 5 min
and supplemented with 10% sodium phosphate buffer pH 2.5.
The reaction product was separated and quantified by high-
pressure liquid chromatography (Waters Associates, USA)
using an ODS-Hypersil column (125 x4.6 mm; 5 \x.m particle
size) (Bischoff GmbH, FRG) and a tiltraviolet monitor
(205 nm; model 481, Waters Associates, USA). For the elu-
tion, a gradient formed with 50 mM NaOH/H3PO4, pH 4.5,
and 40% methanol in 50 mM NaOH/HsPO^ pH 4.5 was used
at room temperature. The flow rate was 1 ml/min and the
running time 25 min.
Preparation of periplasmic fractions
Spheroplasts from exponential-phase cells harboring
pLFl-5 (after a temperature shift to 42 "C) were prepared with
lysozyme as described by Osbom et al. [25]. To avoid cell lysis,
suspensions containing a maximum of 50% spheroplasts (as
monitored by phase-contrast microscopy) were centrifuged at
5000xg for 10 min at 4°C. The proteins in the supematant
fractions were precipitated with trichloroacetic acid and ana-
lysed by SDS-PAGE.
Polyacrylamide gel electrophoresis and electrofocusing
The techniques of Lugtenberg et al. [24] (8% acryiamide
running gel) and O'Farrell [26] (5% slab gels with 2%
ampholines pH 3.5—10.0) were used.
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DNA sequencing
The dideoxy-nucleotide sequencing method [27] was used
(Amersham DNA sequencing kit no.4502).
Hydropathy plots
The program of Pustell and Kafatos [28] was used. It
gives the average hydropathy of 9-amino-acid segments as it
proceeds to the carboxyl terminus of the polyjjeptide.
Other methods
Protein contents were measured using the Lowry method
[29].
Crystallization of PBPS and PBPSS
The purified membrane-bound PBP5 and the water-sol-
uble PBP5S were crystallized using the vapour diffusion tech-
nique of McPherson [30]. A solution containing the purified
membrane-bound PBP5 (4.7 mg protein ml" ' in 25 mM Tris/
HCl pH 8.0 containing 1 mM dithiothreitol, 0.2% Triton X-
100 and 0.5 mM NaCl) was dialysed against 0.1 M sodium
cacodylate pH 6.0 containing 0.5% octylpolyoxyethylene.
After centrifugation (in order to remove any possible material
in suspension), 5-nl drops of the protein solution were (a)
mixed with 5 nl cacodylate/octylpolyoxyethylene buffer sup-
plemented with 1 M NaCl and 18% 4-kDa poly-
(ethyleneglycol); (b) suspended on silanized microscope
coverslips over wells filled up with 1 ml cacodylate/octyl-
polyoxyethylene buffer containing varying concentrations of
NaCl (above 1 M) and 4-kDa poly(ethyleneglycol) (above
18%); and (c) allowed to equilibrate at 18"C.
For the purified, water-soluble PBP5S, more than 1000
crystallization trials were conducted in order to test the effects
of the protein concentration, pH value, buffer composition,
nature of the precipitant and presence of additives. The ad-
dition of 1—5% giycerol, ethyleneglycol, methyl-2,4-
pentanediol and mesoerythrol had a favorable effect on the
crystal habit. The following conditions were eventually
adopted. Drops (10 nl) of a freshly centrifuged solution of
PBP5S (10 mg protein ml" ' in 50 mM Tris/HCl pH 7.8 con-
taining 10 mM NaN3 and 1 mM dithiothreitol) were mixed
with 3 nl Tris/NaN3/dithiothreitol buffer supplemented with
3% (NH4)2S04,1 M NaCl, 16% 10-kDa poly(ethyleneglycol)
and 3% methyl-2,4-pentanediol. A four-day equilibration at
18"C against 1 ml Tris buffer containing 10-kDa poly-
(ethyleneglycol) (16%) yielded well-formed crystals.
X-ray diffraction
The crystallized native PBP5 was studied using a
synchroton radiation source and an oscillation camera
(LURE, Orsay, France, and DESY, EMBL station, Hamburg,
FRG). Crystals of the PBP5S were analysed by precession
photography and the unit-cell dimensions were refined on a
Stoe-Siemens, four-circle X-ray diffractometer.
RESULTS
Construction and characterization of recombinant plasmids
coding for water-soluble PBPSS
Attempts to crystallize the native, membrane-bound
penicillin-binding protein 5 in the presence of detergent
Fig. 1. Construction of replication-control plasmids coding for the trunc-
ated, water-soluble PBP5S. The dacA gene coding for PBP5 was isolat-
ed from plasmid pBS59 [18], shortened and introduced into the run-
away replication control plasmid pWKL-6I. For this purpose. pBS59
was cleaved with EcoKl, partially digested with Bal31, cleaved with
BamHl and filled-in with Klenow enzyme. Fragments ranging from
1.2 kb to 1.3 kb were isolated and finally cloned into the filled-in
BamHl sites of pWKL-61 yielding the collection of pLFl -X plasmids.
Plasmid pKW-61 is a derivative of pOU-61 [19], a runaway re-
plication-control plasmid carrying a kanamycin-resistant gene. To
obtain pWKL-61. a 0.3-kb SamHI-£coRI fragment from pKK232-8
was introduced into pWK-61. This 0.3-kb fragment of known se-
quence [20] carries stop codons (bold type) in all three possible reading
frames: GATCCGTCGACCTGCAGCCAAGCTTGAGTAGGAC-
AAATCCCGCCGAGCTTCGACGAGATTTTCAGGAGCTAA.
Depending on the reading frame used, peptide tails of 8 (TGA), 9
(TAG) or 23 (TAA) amino acids were fused to the truncated PBP5
derivative. Abbreviations used: Ap" = ampicillin resistance; Km" =
kanamycin resistance; Cm" = chloramphenicol resistance. Restric-
tion sites: B, BamHl; E, £coRl. The position of translation stop
codons is indicated by an arrowhead
yielded crystals not suitable for X-ray analysis (see below).
Therefore, it was decided to construct a water-soluble deriva-
tive of PBP5. For this purpose the plasmid pBS-59 [18] was
used as a source of the PBP5-encoding gene. The excised
dacA gene was shortened at the carboxyl-coding end and
the truncated gene was cloned into the runaway replication
control plasmid pWKL-61 in such a way that it was adjacent
to a sequence containing stop codons in all three possible
reading frames, replacing the original translation stop codon
(for details see legend of Fig.l). The plasmid pWKL-61 (a
kanamycin-resistance-coding derivative of plasmid pOU-61;





Fig.2. Comparison of PBP5 and PBP5S by western blots. To ensure
identical overexpression and processing ofthe proteins, two plasmids
from the pLFl-X collection were chosen. One of them, pLFl-5,
expressed PBP5S, the other carried the intact dacA gene including the
original translation stop codon (sequencing data not shown). Both
plasmids were overexpressed in E. coli HBlOl by growth at 42 °C.
The membrane and soluble fractions prepared from cell extracts were
analysed by westem blots (Materials and Methods). Tracks 1, 2 and
3: total extract, membrane and soluble fraction of E. coli cells express-
ing the wild-type PBP5. Tracks 4, 5 and 6: total extract, membrane
and soluble fraction of E. coli cells expressing PBP5S. The non-
plasmid-coded PBP5 of the host cell does not appear because of its
low amount compared with the overexpressed protein. The gels were
overloaded to reveal possible degradation products; because of the
overloading the small difference in molecular masses of PBP5 and
PBP5S is not apparent, the bands are not doublets
coded proteins after raising the growth temperature of the
host above 35 °C. The introduction of the shortened dacA
gene into pWKL-61 yielded several plasmids (pLFl-X). One
of them, pLFl-5, coded for a water-soluble form of PBP5
which was highly stable, not associated with the cytoplasmic
membrane (Fig. 2) and enzymatically fully active. Analysis of
the supematant fraction from lysozyme-induced spheroplasts
demonstrated that the overproduced water-soluble PBP5 de-
rivative was localized in the periplasm (data not shown). This
truncated protein was called PBP5S.
Isolation and properties of PBPSS
After a temperature-shift to 42°C of £. coli HBlOl, trans-
formed with pLFl-5, PBP5S was isolated in milligram
amounts from cell extracts by single-step aflinity chromatog-
raphy on CH-Sepharose 4B coupled with 6-aminopenicillanic
add (Fig.3). The purified protein was concentrated up to
13 mg protein ml" ' by an absorption/elution cycle on
heparin-Sepharose (for details, see Materials and Methods).
No membrane solubilization was necessary and no chaotropic
agents or detergents had to be used at any step ofthe isolation,
purification and concentration procedure. The final yield was
about 0.3 mg PBP5S/g, wet mass, of cells. PBP5S represented
0.5 — 1% of the total water-soluble proteins present in the
combined cytoplasmic and periplasmic fractions. PBP5S was
stable upon storage at — 20 °C for at least four months, even
after several freezing and thawing cycles.
PBP5S was compared to the wild-type, membrane-bound
PBP5 purified to protein homogeneity (as described in Ma-
terials and Methods). Triton X-100 had to be present at each
step of the purification procedure in order to avoid precipi-
tation and to ensure enzyme activity of PBP5. The DD-
carboxypeptidase activity of PBP5S (with the depsipeptide
carbonyl donor Ac2-L-Lys-D-Ala-D-lactate as a substrate) was
Triton-independent (Fig.4). As expected, the detergent en-
hanced the enzymic activity of PBP5 but, even, with detergent,
PBP5 was less active than PBP5S [specific activities: 23 pmol
and 50 pmol product formed min " * (ng PBP5 and PBP5S)"'
respectively]. Derivatization of PBP5S and PBP5 with ["*C]-
benzylpenicillin gave rise to acyl-(['*C]penicilloyl)enzymes
with comparable, rather short lives (8 and 5 min respectively;
data not shown).
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Fig. 3. Purification ofPBP5S by affinity chromatography. Coomassie-
blue-stained SDS-PAGE ofthe soluble fraction of cell extracts (300 ng
protein; track 1) and of the first hydroxylamine eluate obtained at
room temperature (4 ng protein; track 2:). For details see Materials
and Methods. Molectilar mass markers are indicated
60
Fig.4. Time course of hydrolysis ofthe depsipeptide Aci-Lys-D-Ala-D-
Lactate (140 /xM) by equimolar amounts of PBP5 and PBP5S (1 fiM).
For details see Materials and Methods. PBP5S ( • , A) and PBP5 (O,
A) were assayed with (A, A) or without ( • , O) 0.2% Triton X-100
The comparison of the carboxyl-terminal portion of
PBP5S with that of PBP5 (as deduced from nucleotide
sequencing) (Fig.5) showed that the last 21 amino acids of
PBP5 were replaced in PBP5S by a 9-amino-acid sequence
possessing 2 arginine and 1 lysine residues. This modification
caused the elimination of the hydrophobic segment Phe^'^-
j^ yg366 fj.Qjjj PBP5, which anchors the protein in the mem-
brane. The average isoelectric point of the amino acids in the
modified sequence of PBP5S is more basic than that in native
PBP5. This well explains the increased isoelectric point of
PBP5S when compared to that of PBP5 (i.e. 5.9 versus 5.5;
data not shown).
Crystallization of PBPS and PBPSS
PBP5 gave rise to crystals in the form of very thin plates
that grew up to 0.1 mm in length and 10 nm in width. All
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Fig. 5. Sequence and hydropathy plot ofthe terminal amino acidsegment
ofPBP5 (A) and PBP5S (B) (as deduced from nucleotide sequencing;
see Materials and Methods). The arrows indicate the points of trunc-
ation
attempts yielded crystals of the same type, not suitable for
high-resolution X-ray analysis. Inspection of photographs of
PBP5 gave the following approximative unit-cell dimensions:
a % 4.8 nm; A « 5.7 nm; c a; 11.9 nm. PBP5S gave rise to
well-formed prismatic crystals (Fig.6) which diffracted to at
least 0.3 nm. The space group was Pl^ and the unit-cell dimen-
sions (using 15 reflections) were: a = 4.651 nm; b = 5.693 nm;
c = 8.000 nm; )? = 106.5"C. Assuming one 42-kDa protein
molecule per asynimetric unit, a specific volume of
0.00254 nm'/Da was calculated. This value was within the
range found for protein crystals [31]. The crystals were very
stable in the X-ray beam. When exposed to the /?-lactam
nitrocefin (0.1 mM in mother liquor), they became red after
10 min at 18°C, as a result ofthe catalysed hydrolysis ofthe
/?-lactam amide bond.
DISCUSSION
The attachment of the low-molecular-mass PBPs 5 of Ba-
cillus stearothermophilus, B. subtilis and E. coli to the plasma
membrane (or to lipid vesicles) is mediated by a C-terminal
segment [16, 32 — 34]. After solubilization with a detergent,
micelles are supposed to provide an environment that ensures
the insertion of the isolated protein, correct polypeptide fold-
ing and generation of a functional enzyme's active site [32,
35].
Water-soluble DD-peptidases/PBPs have been obtained
from B. stearothermophilus and Streptococcus faecalis by pro-
teolytic treatment of the corresponding plasma membranes
[32,36]. Moreover, Streptomyces R61 excretes a water-soluble
DD-peptidase/PBP during growth [37]. This PBP is synthesized
as a precursor that possesses both a cleavable amino-terminal
extension, which has the characteristics of a signal peptide,
and a cleavable C-terminal extension. Should it not be re-
moved during protein maturation, this carboxyl-terminal ex-
tension might function as a halting signal through which
the enzyme would become membrane-bound [38]. All these
experimental data lead to the conclusion that DD-peptidase
Fig.6. Crystallized PBP5S. For conditions of crystallization, see Ma-
terials and Methods
and penicillin-binding activities do not require membrane in-
sertion and, as a corollary, that the active sites of the
membrane-bound enzymes are, in all Ukelihood, exposed to
the periplasm of the cell close to their substrate, i.e. the
murein. Membrane insertion, however, might be important
for the in vivo regulation of the enzyme activity of the PBPs
and/or for association with other cell-envelope components.
Recently the PBP5 off. co//has been converted into water-
soluble derivatives by removing amino acids at the carboxyl
terminus [16] using a cloning strategy similar to that described
here. However, some of the resulting truncated proteins were
unstable, none of them cotild be overproduced after cloning
into high-copy-number plasmids (J. Pratt, personal communi-
cation) and their enzymatic activity and interaction with
['''C]benzylpenicillin were not analyzed. The observed re-
duced stability may result from the introduction of hydro-
phobic amino acids at the truncated ends coded by the inserted
oligonucleotide stop fragments. In contrast, PBP5S can be
overproduced and is both stable and enzymatically active in
the absence of detergent. Its stability may result from the fact
that the trtmcated carboxyl terminus carries several highly
hydrophilic amino acids (Fig. 5).
The specific activity of PBP5S in the absence of detergent
is twice that of the wild-type protein as measured in the
presence of Triton X-100, a property reminiscent of that of
the water-soluble proteolytic fragments obtained from the DD-
peptidases/PBPs of B. stearothermophilus and S. faecalis [32,
36]. These fragments also have a higher specific activity than
the wild-type parents. Removal ofthe detergent leaves PBP5S
fully active whereas the activity of the wild-type protein is
completely abolished. The higher specific activity ofthe water-
soluble PBP5, as compared to the intact PBP5 when measured
in the presence of Triton X-100, may be due to the distribution
of PBP5 both on the inner and outer sides of the micelles,
whereas the substrate has access to the outside only.
A possible mechanism for the emergence of active-site
serine /?-lactamases in the bacterial world is that bacteria
exposed to ^-lactam antibiotics once excreted one or several
(non-essential) PBPs in their environment or the periplasmic
compartment [12]. Ftirther improvement ofthis detoxification
mechanism resulted in the conversion of these water-soluble
PBPs into jS-lactam-hydrolysing enzymes. The likelihood of
this hypothesis rests upon the similarity ofthe spatial arrange-
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ment of secondary structures, shown by several /J-lactamases
and the extracellular, water-soluble DD-peptidase/PBP of
Streptomyces R61 [10 — 13]. In addition to this naturally oc-
curring water-soluble PBP, the work described here has given
access to a genetically engineered, water-soluble PBP5 from
E. coli. The establishment of the three-dimensional structure
of these two PBPs is in progress. They may become models
of choice for experiments aimed to reproduce in vitro the
proposed evolutionary transition from PBPs to )S-lactamases.
Since membrane-bound jjenicillin-binding proteins play a key
role in the metabolism of murein [1], which is responsible for
the maintenance of bacterial shape [39], structtiral data on
PBPs will also help in understanding problems related to
bacterial morphogenesis and cell division.
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